Congratulations on the successful convening and conclusion of the Inaugural Meeting of the Testing Branch of the Heilongjiang Provincial Society of Animal Husbandry and Veterinary Medicine and the Laboratory Testing Technology Forum.

On March 29, the Testing Branch of the Heilongjiang Provincial Society of Animal Husbandry and Veterinary Medicine held its inaugural meeting and concurrently convened a Laboratory Testing Technology Forum. Guangzhou Weiboxin Biotechnology Co., Ltd. (Expert in Rapid Detection and Diagnosis of Animal Epidemics) Also attending by invitation! 
 

Promote the development of the veterinary inspection and testing industry, enhance the standards and technical capabilities of veterinary inspection and testing, strengthen academic exchange and collaboration in this field, cultivate specialized professionals in veterinary inspection and testing, improve the quality and efficiency of veterinary inspection and testing services, facilitate the translation and application of research findings in veterinary inspection and testing, provide robust support for the prevention and control of animal epidemics and for veterinary public health and safety, and ensure sustainable and healthy livestock production. Guangzhou Wei Boxin carries this great responsibility on his shoulders and embraces his mission wholeheartedly—there is no room for hesitation.

Guangzhou Weiboxin is a high-tech enterprise specializing in the R&D, manufacturing, sales, and technical services of diagnostic reagents for animal infectious diseases.

At the recently concluded Testing Sub-conference of the Heilongjiang Provincial Society of Animal Husbandry and Veterinary Medicine, Guangzhou Weiboxin Biotechnology showcased its cutting-edge animal disease detection products, drawing the attention of numerous customers and industry peers. The company’s lyophilized products, in particular, garnered widespread interest, demonstrating Weiboxin’s… In terms of technological innovation and quality control its strength. The company’s products are now widely used across the country and have earned high recognition from a broad base of customers.

Weiboxin Company’s products cover Molecular Diagnostics and Immunological Testing and other fields, Able to meet the market’s diverse needs During the exhibition, customers provided positive feedback on the company’s products and services and expressed appreciation for the company’s development and innovative capabilities.

On-site booths attracted customers to stop by for visits and inquiries.

Guangzhou Weiboxin will continue to dedicate itself to technological innovation, safeguarding animal health. We extend our heartfelt gratitude to all our customers and partners for their support and trust, and look forward to even greater collaboration and development together!

When looking for animal disease testing reagents, choose the Weiboxin brand.

Be aware of Weiboxin Bio All products of!

Official consultation phone numbers: 020-66377266 / 135 3988 6748, Ms. Dai

Guangzhou Weiboxin Biotechnology Co., Ltd. is located in the national-level innovation park—Guangzhou Science City. The company is a provincial-level “Little Giant” high-tech enterprise specializing in the forward R&D, manufacturing, sales, and technical services of diagnostic reagents for animal epidemics. It has been recognized as a “Contract-Honoring and Credit-Keeping Enterprise” by Guangdong Province and as a “Provincial Intellectual Property Demonstration Unit.” Additionally, it serves as an industry–university–research collaboration base for Guangdong Food and Drug Vocational College and as an executive director unit of the Veterinary Diagnostic and Biological Products Committee of the Guangdong Society of Animal Husbandry and Veterinary Medicine. The company has been designated as an innovative, high-potential enterprise by multiple research institutions, including the Entrepreneurship College of Jinan University in Guangdong Province, and has been awarded the titles of “Specialized, Refined, Distinctive, and Innovative” enterprise at both municipal and provincial levels. It has also received the “Most Investment-Valuable Enterprise” award and the annual title of “ASF and Swine Disease Testing Service Provider.” Furthermore, its veterinary drug product has been granted an approval number by the Ministry of Agriculture and Rural Affairs: Veterinary Drug Registration No. 191438923 (African Swine Fever Virus Fluorescent PCR Diagnostic Kit). The company won the Excellence Award in the Growth Category of the Biopharmaceutical Industry at the 11th China Innovation and Entrepreneurship Competition, secured the Provincial Second Prize in the Growth Category of the Nanotechnology Industry Technology Competition, and earned the National Third Prize in the Growth Category of the National Finals of the Nanotechnology Industry Technology Innovation Special Competition within the China Innovation and Entrepreneurship Competition. It has consecutively received the A-Level Tax Credit Honor Certificate, the Four-Star Trademark Brand Certification, and the Two-Integration Management System Assessment Certificate each year. In addition, it holds ISO 9001 International Quality Management System Certification, ISO 14001 International Environmental Management System Certification, and GMP certification from the Ministry of Agriculture. Since its establishment, the company has been granted a total of 24 patents, including 5 invention patents, 15 utility model patents, and 4 design patents, along with more than ten trademarks.

The company boasts robust technical capabilities and a team of world-class professionals, including dozens of masters, doctors, and returnees who studied abroad, as well as numerous senior-title technical experts. Currently, the company’s primary focus is on the research and development of molecular diagnostic reagents. Its core R&D team has developed more than 600 products spanning molecular diagnostics and immunoassays, including public-health–oriented fluorescent PCR test kits, animal disease–control–oriented fluorescent PCR test kits, clinical and research–grade fluorescent quantitative PCR kits, and transgenic identification test kits (ZL2006). The company has also established a nationwide distribution network covering more than ten major cities, such as Beijing, Shanghai, Hangzhou, Nanjing, Xi’an, Chongqing, Lanzhou, Zhengzhou, and Qingdao.

Looking ahead, Weiboxin will remain steadfast in its commitment to continuously enhance product quality and service standards. Leveraging a rapid and efficient research platform and abundant biomedical resources, we will conduct extensive and in-depth R&D and scientific research in the biomedical field, thereby contributing to human health and advancing life sciences. Quality is our lifeline, and innovation is our soul; we will unwaveringly uphold this philosophy as we strive to become the premier supplier of rapid diagnostic reagents and instruments.